Magnus Öhman – Chairman
Member of the board since 2023, Chairman of the Board from 2024
Board of Director assignments:
Magnus is currently Chairman of the board of Neosense Technologies, a Swedish medtech start-up company that develops invasive sensor based products where the first product significantly improves continuous oxygen monitoring for neonatal children to improve survival rate and Quality of Life. He has been a board member at Stockholms Tekniska Institut, an engineering school founded in 1924.
Experience:
Magnus has over 30 years of experience from medtech including R&D leadership in both site and global responsibilities and as Managing Director for the St Jude Medical CRM subsidiary with R&D, manufacturing and distribution operations with over 600 employees and a revenue of 5.3 billion SEK. Magnus has managed or supervised 40+ product developments projects from start to regulatory approved and launched globally.
Magnus previously served as CEO of Stockholms Tekniska Institut, an engineering school with 350+ students managing a turnaround operationally and strategically.
Independent in relation to the company and its management and from major shareholders.
Azad Najar – Board Member
Born: 1968
Education: Medical doctor
Holding (together with related parties): 3 272 635 shares.
Member of the board since 2008
Board of Director assignments:
Laprotech AB and Najar Medical and Invention AB
Experience:
Azad Najar is one of the founders of Realheart and is the main innovator behind Realheart TAH. Azad originates from Iraqi Kurdistan, is a licenced doctor and works part time as Chief Physician at the Department of Urology at Västmanlands hospital in Västerås, Sweden. Najar has worked with research and development of the artificial heart since 1999.
Dependent in relation to the company and its management and from major shareholders.
Oliver Voigt– Board Member
Born: 1973
Education: Biomedical engineer and certified clinical engineer. Executive MBA in Entrepreneurship and Leadership
Holding (together with related parties): 3 236 shares
Member of the board since 2022
Board of Director assignments: –
Experience:
Oliver has 25 years of experience in the field of artificial hearts and mechanical circulation support. He started at the German Heart Institute Berlin as a VAD engineer and worked with the original developer of the Berlin Heart VAD / TAH system. He then switched to the industry to introduce and secure clinical support for the world’s first non-pulsating long-term LVAD developed jointly by NASA and Dr. DeBakey (Houston). After completing his MBA, Oliver has worked as Managing Director in Europe for SynCardia (TAH) to successfully lead the international expansion and build the TAH market from two to 26 countries in the EU and the Middle East. He continues to work as Managing Director for Evaheart (LVAD) within the EU and in Asia.
Independent in relation to the company and its management and from major shareholders.
Solveig Bergström – Board Member
Born: 1944
Education:MSc in Financing Psychology and BSc in Business Administration in Economics and has studied distribution.
Holding (together with related parties): –
Member of the board since 2022
Board of Director assignments:
Solveig currently has a seat on the board of Novosense, a Swedish start-up company that develops wireless sensor systems for medical applications, including cardiovascular applications. She has been chairman of the board (former CEO) of Fixter Instruments AB, a company that developed medical equipment and instruments (sold to an international company).
Experience:
Solveig has over 30 years of experience from leading companies in various stages and sizes, including the entire progression from start-up, growth, establishment of international subsidiaries to M&A and sales. She was responsible for the business development area of health, as part of the management team at LM Ericsson, including operational management of international projects and business activities, gathering expertise in the European groups, establishing international committees and founding international medical groups. She has also been responsible for Life Science / Health Care industry issues at Invest in Sweden Agency (ISA) when the company started its operations in 1996 (later merged with the Swedish Trade Council to become Business Sweden).
Independent in relation to the company and its management and from major shareholders.
Giovanni Lauricella – Board Member
Born: 1987
Education: Bachelor’s in Finance and a Master’s in Regulatory Affairs in Medical Devices
Holding (together with related parties): –
Member of the board since 2023
Board of Director/Ongoing assignments:
Managing Partner at Lifeblood, a recruitment and consulting firm for executives and specialists, where he has 15 years of experience in designing and building teams exclusively for the global Med-Tech industry. Giovanni is also a board member of privately held Vivifi Medical, a medical device company. He is also an active angel investor and limited partner in venture capital funds.
Experience:
Giovanni has travelled to 40+ countries and has assisted 500+ startups with talent acquisition and fundraising strategies leading to more than 2,000 hires, $300 million in raised capital, and $4 billion in acquisitions.
Independent in relation to the company and its management and from major shareholders.
Stuart McConchie – Board Member
Born: 1952
Education: Bachelor of Science (BSc) in Pharmacology – Monash University, Melbourne, Australia.
Holding
(together with related parties): –
Member of the board since 2023
Board of Director assignments:
Stuart is Chairman and CEO of Galvani Tech Ltd, which develops energy transfer systems for medical devices.
Experience:
Stuart McConchie has over thirty years of senior management experience in the global high-tech medical device industry, Stuart has approximately 20 years of LVAD experience as former CEO of Calon Cardio-Technology and Heartware, and as former COO of Jarvik Heart. He also has 17 years of experience in pacemakers from his role as Vice President at Teletronics.
Independent in relation to the company and its management and from major shareholders.
